Contact us

877-469-1TRM
424-208-8866

A Study of Oral Ixazomib Maintenance Therapy in Patients With Newly Diagnosed Multiple Myeloma Not Treated With Stem Cell Transplantation

A Phase 3, Randomized, Placebo-Controlled, Double-Blind Study of Oral Ixazomib Maintenance Therapy After Initial Therapy in Patients With Newly Diagnosed Multiple Myeloma Not Treated With Stem Cell Transplantation

For more information, please visit ClinicalTrials.gov

Patient Population Investigational Product(s) Phase Status
Multiple Myeloma Ixazomib III Open and Accruing